About Embody
Embody is a company based in Norfolk (United States) founded in 2014 by Michael Francis was acquired by Zimmer Biomet in January 2023. Embody has raised $41.4 million across 14 funding rounds from investors including HHS, DARPA and Zimmer Biomet. The company has 25 employees as of December 31, 2021. Embody operates in a competitive market with competitors including Miach Orthopaedics, Collplant, Nanochon, GeniPhys and Nurami Medical, among others.
- Headquarter Norfolk, United States
- Employees 25 as on 31 Dec, 2021
- Founders Michael Francis
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Embody, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$41.4 M (USD)
in 14 rounds
-
Latest Funding Round
$10.4 M (USD), Series C
Sep 20, 2022
-
Investors
HHS
& 8 more
-
Employee Count
25
as on Dec 31, 2021
-
Acquired by
Zimmer Biomet
(Jan 05, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Embody
Unlock access to complete
Funding Insights of Embody
Embody has successfully raised a total of $41.4M across 14 strategic funding rounds. The most recent funding activity was a Series C round of $10.4 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Embody
Embody has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, DARPA and Zimmer Biomet.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital funding for medical device companies is provided.
|
Locked | Locked | Locked | |
|
Structured debt is provided to life sciences and technology firms.
|
Locked | Locked | Locked | |
|
Early-stage VC firm funding companies in the US
|
Locked | Locked | Locked |
Investor details for Embody
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Embody
Investment portfolio details for Embody
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Embody
Detailed financials for Embody
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Embody Comparisons
Peer comparison for Embody
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Embody
Embody operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Miach Orthopaedics, Collplant, Nanochon, GeniPhys and Nurami Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Bio-engineered surgical implants for connective tissue repair are developed.
|
|
| Locked | Locked | Locked |
Plant-derived collagen is developed for tissue repair and 3D bioprinting.
|
|
| Locked | Locked | Locked |
3D-printed implants are developed for treating joint injuries.
|
|
| Locked | Locked | Locked |
Collagen polymers are developed for tissue regeneration applications.
|
|
| Locked | Locked | Locked |
Nanofiber and sealant technology for soft tissue repair is developed.
|
|
| Locked | Locked | Locked |
A rotator cuff repair system is developed for disease treatment.
|
Detailed competitors of Embody
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Embody
Complete news archive for Embody
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Embody
Embody was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Embody is headquartered in Norfolk, United States. It is registered at Norfolk, Virginia, United States.
Embody is a funded company, having raised a total of $41.4M across 14 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Embody is 25.
Founded in 2014 and based in Norfolk, United States, collagen-based regenerative matrices for soft tissue repair are developed by the company. Manufacturing platforms incorporating electrospinning and microfluidics are utilized in operations. Applications include drug delivery and wound healing, with products such as the Tapestry biointegrative Implant, Microbraid collagen suture, and Microbrace offered in the regenerative medicine sector.
Embody's top competitors include Miach Orthopaedics, Collplant and Jellatech.
Embody has 9 investors. Key investors include HHS, DARPA, Zimmer Biomet, Horizon Tech Finance, and cultivate(MD).